Pacific Biosciences of California Inc

NASDAQ: PACB    
Share price (5/17/24): $2.02    
Market cap (5/17/24): $550 million
18 Pacific Biosciences of California Inc Expert Interviews, now on BamSEC.
 Powered by Tegus.

Material Contracts Filter

EX-10.28
from 10-K 6 pages Material contract
12/34/56
EX-10.1
from 8-K 5 pages June 23, 2023 A
12/34/56
EX-10.27
from 10-K 5 pages Pacific Biosciences of California, Inc. 2020 Equity Incentive Plan Performance-Based Restricted Stock Unit Agreement Notice of Restricted Stock Unit Grant
12/34/56
EX-10.1
from 10-Q 17 pages Background
12/34/56
EX-10.3
from 8-K 17 pages Pacific Biosciences of California, Inc. 2020 Equity Incentive Plan Global Restricted Stock Unit Agreement Notice of Restricted Stock Unit Grant
12/34/56
EX-10.2
from 8-K 20 pages Pacific Biosciences of California, Inc. 2020 Equity Incentive Plan Global Stock Option Agreement Notice of Stock Option Grant
12/34/56
EX-10.1
from 8-K 17 pages Pacific Biosciences of California, Inc. 2020 Equity Incentive Plan
12/34/56
EX-10.2
from 10-Q 13 pages Pacific Biosciences of California, Inc. Change in Control and Severance Agreement
12/34/56
EX-10.1
from 8-K 60 pages Pacific Biosciences of California, Inc. 2020 Inducement Equity Incentive Plan
12/34/56
EX-10.4
from 10-Q 57 pages Omniome Equity Incentive Plan of Pacific Biosciences of California, Inc
12/34/56
EX-10.6
from 10-Q 2 pages Certain Confidential Information Contained in This Document, Marked by Brackets ([***]), Has Been Omitted Because the Information (I) Is Not Material and (II) Would Be Competitively Harmful if Publicly Disclosed
12/34/56
EX-10.2
from 10-Q 3 pages  March 23, 2021   Michele Farmer   Dear Michele,  on Behalf of Pacific Biosciences of California, Inc. (The “Company”), I Am Pleased to Offer You a Position at the Company as Chief Accounting Officer. You Will Be Reporting to Susan Kim.  You Will Receive a Salary of $295,000 Annually, Paid Twice Monthly According to the Company’s Payroll Schedule. 
12/34/56
EX-10.3
from 8-K 26 pages Registration Rights Agreement
12/34/56
EX-10.2
from 8-K 37 pages Securities Purchase Agreement Recitals
12/34/56
EX-10.1
from 8-K 114 pages Agreement and Plan of Merger and Plan of Reorganization Among Pacific Biosciences of California, Inc. Apollo Acquisition Corp. Apollo Acquisition Sub, LLC. Omniome, Inc. and Shareholder Representative Services LLC, as Securityholder Representative July 19, 2021
12/34/56
EX-10.1
from 8-K 58 pages Pacific Biosciences of California, Inc. 2020 Inducement Equity Incentive Plan
12/34/56
EX-10.25
from 10-K 11 pages  Certain Confidential Information Contained in This Document, Marked by Brackets ([***]), Has Been Omitted Because the Information (I) Is Not Material and (II) Would Be Competitively Harmful if Publicly Disclosed. Exclusive License Agreement
12/34/56
EX-10.23
from 10-K 40 pages Development and Commercialization Agreement
12/34/56
EX-10.19
from 10-K 4 pages December 7, 2020   Peter Fromen 18 Stukeley St., Flat 5 London Wc2b 5lr United Kingdom   Dear Peter, 
12/34/56
EX-10.18
from 10-K 3 pages December 9, 2020  Mark Van Oene 4763 Sun Valley Rd Del Mar, Ca 92014   Dear Mark,  on Behalf of Pacific Biosciences of California, Inc. (Or “The Company”), I Am Pleased to Offer You a Position at the Company as Chief Operating Officer. You Will Be Reporting to Christian Henry.  You Will Receive a Salary of $550,000 Annually, Paid Twice Monthly According to the Company’s Payroll Schedule.  You Will Also Be Eligible to Participate in the Employee Incentive Bonus Plan (The “Bonus Plan”) With a Target of 60% of Your Base Salary (Subject to the Company’s Achievement of Certain Corporate Goals and Objectives). the Details of the Bonus Plan Are Set Forth in the Employee Handbook. 
12/34/56